| Net loss | 1.99M |
| Depreciation and amortization | |
| Stock-based compensation, net | 760K |
| Loss on disposal of long-lived assets and assets held for sale | |
| Loss on write-down of contigent consideration held in escrow | |
| Deferred income taxes | -1K |
| Accounts receivable, net | |
| Inventories, net | -2.28M |
| Income taxes receivable | |
| Prepaid expenses and other | |
| Accounts payable | -1.47M |
| Deferred revenue | 1.1M |
| Accrued and other long-term liabilities | -343K |
| Net cash used in operating activities | |
| Purchase of marketable securities | |
| Proceeds from sale of marketable securities | |
| Decrease in restricted cash | |
| Purchase of fixed assets | -1.92M |
| Proceeds from sale of fixed assets and assets held for sale | |
| Cash paid for acquisition, net of cash acquired | |
| Net cash used in investing activities | |
| Principal payments on capital lease obligations | |
| Withholding taxes paid on net settlement of vested restricted stock units | -372K |
| Proceeds from issuances of common stock | 171K |
| Net cash provided by (used in) financing activities | |
| Effect of exchange rate changes on cash | 488K |
| Decrease in cash and cash equivalents | 2.8M |
| Beginning of period | 32.11M |
| End of period | 34.91M |
| Refunds received (cash paid) for income taxes, net | 1.05M |
| Common stock issued in connection with acquisition | |
| Fair value of assets acquired from acquisition | |
| Liabilities assumed from acquisition | |